ArticleActa pharmacologica Sinica2021

Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin.

Xiao-Ming Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.